Dr. Tierra L Mosher, United States
Cost-Effectiveness of Adolescent-Initiated Semaglutide for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Modeled Implications for Long-Term Liver Transplantation Risk
Dr. Tyler J York, United States
Initial Experience with Post-Operative Contrast Enhanced Ultrasound Following Pediatric Whole and Partial Deceased Donor Liver Transplant
David Lee, United States
Successful outcomes with ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression protocols with selective use of desensitization therapy
Mr. Joshua Badshah, United States
Stability-Selected Machine Learning Identifies Key Determinants of Early Graft Failure in Pediatric Liver Transplantation
Wendy Sevilla, United States
BOLD and BOLD-EXT, the first global phase III clinical program to evaluate the long-term efficacy and safety of odevixibat in infants with biliary atresia after Kasai hepatoportoenterostomy – study design and current status
Dr. Ashritha Avalareddy, India
The PRO-KASAI Study: Primary vs Rescue Liver Transplant Outcomes in Children With Biliary Atresia (BA) After Kasai Portoenterostomy (KPE) – Analysis of the Indian Liver Transplant Registry
Dr. Forum Patel, United States
Terlipressin therapy for portal hyperperfusion secondary to portal vein size discrepancy after pediatric liver transplant
Dr. Blake Rosenthal, United States
Quality improvement project: age-based order set for diagnostic evaluation of pediatric patients presenting in acute Liver failure
Ahmad Salah Sami, United States
Tacrolimus: Old drug, new tricks to reduce early acute T cell-mediated rejection rates in pediatric liver transplant recipients
Dr. Diana C Altamirano Montealvo, Mexico
Implementation of a pediatric living donor liver transplantation program in a tertiary care hospital in a developing country
Dr. Anna I Barclay, United States
A Standardized Guidance Document for Pediatric Liver Transplantation in People with Advanced Cystic Fibrosis-Related Liver Disease
Amrita Narang, United States
Feeding the flame, one day at a time: design of a serious game to support medication adherence and education for pediatric liver transplant patients
Dr. Kathryn Czepiel MD MS, United States
Marked muscle wasting in pediatric liver transplant registrants: a retrospective cohort analysis using OPTN data
Dr. Amber Gafur, United States
Social Determinants of Health in Pediatric Metabolic Dysfunction-Associated Steatotic
Liver Disease: Utilizing the Childhood Opportunity Index (COI)
Amala J Alenchery MD, United States
Role of Biologic Therapies in Chronic Allograft Enteropathy in Pediatric Intestinal/Multivisceral Transplantation: A Single Center Experience
Dr. Maria F Nieves Arreola, Mexico
Survival and waitlist mortality in pediatric liver transplantation: a comparative analysis of biliary atresia vs. chronic liver diseases in Mexico
Dr. Ane M Andres, Spain
Auxiliary split-hope liver transplantation from a donation after circulatory death donor as treatment for pediatric acute liver failure: case report
Dr. Samantha Kanterman, United States
EPHB4-related capillary malformation-arteriovenous malformation (CM-AVM) syndrome due to hepatic arteriovenous malformation: a case report
Dr. Arielle Melen, United States
Management of Severe Pediatric Tacrolimus Overdose With Intravenous Fluids and Fosphenytoin-Induced Enzyme Induction: A Case Report
Prof. Maren Schulze, Germany
Hypothermic oxygenated machine perfusion (HOPE) of a partial split liver graft for acute liver failure following amatoxin poisoning.
Email: info@splitmeeting.org
If you have any questions during the meeting, please go to the registration desk. Our emails will be monitored sporadically.